Please assess the completion status of the following clinical trial:

Trial Title: Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Ability to give informed consent~* Lower urinary tract symptoms (LUTS) felt to be secondary to bladder outlet obstruction from benign prostatic hyperplasia~* Maximum urinary flow rate \< 15 ml/sec, voided volume ≥ 125 cc~* American Urological Association symptom score ≥ 9~* Transrectal ultrasound determined prostate volume ≤ 60 cc~Exclusion Criteria:~* Inability to give informed consent~* Maximum urinary flow rate ≥ 15 ml/sec~* Transrectal ultrasound determined prostate volume \> 60cc~* AUA symptom score \< 9~* Active urinary tract infection~* Bleeding diathesis~* Neurological disease that is felt to affect the bladder or a history of a neurogenic or chronically decompensated bladder~* Known prostate cancer~* Active bladder cancer (within the last 2 years)~* Prostate specific antigen (PSA) \> 4.0 unless previous negative biopsy~* Urinary retention~* Post-void residual (PVR) \> 300 cc

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: None): Comparison study between KTP and HoLAP procedures for BPH

Based on this trial design, predict the completion outcome and termination type (if applicable).